Literature DB >> 16881507

Propagation of human embryonic stem cells on human feeder cells.

Mark Richards1, Ariff Bongso.   

Abstract

Human embryonic stem (hES) cell lines are usually derived and propagated on inactivated murine embryonic fibroblast (MEF) feeders. The use of MEFs and culture ingredients of animal origin for hES cell support increases the risk of cross-contamination of the hES cells with infectious animal agents from the MEFs and animal-based culture medium. This thus makes such hES cells lines undesirable for clinical application. This chapter describes several protocols used in the propagation of hES cells on human fibroblast feeder cells. Two culture methods, the bulk enzymatic culture protocol and the microdissection "cut and paste" protocol are described. Only certain human fetal and adult fibroblast feeders support hES cell growth. Methods for the characterization of pluripotent undifferentiated hES cells grown on human feeders including cell surface marker staining and real-time polymerase chain reaction are also described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16881507     DOI: 10.1385/1-59745-046-4:23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  A feeder-free, human plasma-derived hydrogel for maintenance of a human embryonic stem cell phenotype in vitro.

Authors:  Fiona C Lewis; Nicholas Bryan; John A Hunt
Journal:  Cell Regen (Lond)       Date:  2012-08-08

2.  Laminin 521 Stabilizes the Pluripotency Expression Pattern of Human Embryonic Stem Cells Initially Derived on Feeder Cells.

Authors:  Halima Albalushi; Magdalena Kurek; Leif Karlsson; Luise Landreh; Kristín Rós Kjartansdóttir; Olle Söder; Outi Hovatta; Jan-Bernd Stukenborg
Journal:  Stem Cells Int       Date:  2018-02-18       Impact factor: 5.443

3.  "The good into the pot, the bad into the crop!"--a new technology to free stem cells from feeder cells.

Authors:  Annette Schneider; Dimitry Spitkovsky; Peter Riess; Marek Molcanyi; Naidu Kamisetti; Marc Maegele; Jürgen Hescheler; Ute Schaefer
Journal:  PLoS One       Date:  2008-11-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.